New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers develop new brain network modeling tools to advance Alzheimer's disease research

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev
Neurology February 24,2024
Researchers develop new brain network modeling tools to advance Alzheimer's disease research

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev
Neurology February 24,2024
Clues to preventing Alzheimer's come from patient who evaded disease, despite genetics

Clues to preventing Alzheimer's come from patient who evaded disease, despite genetics

by Washington University School of MedicineCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.029Alzheimer's disease has plagued one large Colombian family for generations, striking d
Neurology February 24,2024
Clues to preventing Alzheimer's come from patient who evaded disease, despite genetics

Clues to preventing Alzheimer's come from patient who evaded disease, despite genetics

by Washington University School of MedicineCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.029Alzheimer's disease has plagued one large Colombian family for generations, striking d
Neurology February 24,2024
Black patients face delays in Alzheimer's diagnosis, research finds

Black patients face delays in Alzheimer's diagnosis, research finds

by Radiological Society of North AmericaBrain MRI images. Credit: RSNA/Joshua Wibecan, M.D.Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic pa
Neurology February 24,2024
Black patients face delays in Alzheimer's diagnosis, research finds

Black patients face delays in Alzheimer's diagnosis, research finds

by Radiological Society of North AmericaBrain MRI images. Credit: RSNA/Joshua Wibecan, M.D.Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic pa
Neurology February 24,2024
Adults with ADHD are at increased risk for developing dementia, study suggests

Adults with ADHD are at increased risk for developing dementia, study suggests

by Rutgers UniversityCredit: Unsplash/CC0 Public DomainAdults with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop dementia than adults without ADHD,
Neurology February 24,2024
Adults with ADHD are at increased risk for developing dementia, study suggests

Adults with ADHD are at increased risk for developing dementia, study suggests

by Rutgers UniversityCredit: Unsplash/CC0 Public DomainAdults with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop dementia than adults without ADHD,
Neurology February 24,2024
Experimental therapy eases Alzheimer's signs, symptoms in mice

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (
Neurology February 24,2024
Experimental therapy eases Alzheimer's signs, symptoms in mice

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (
Neurology February 24,2024
Negative wealth shock linked to accelerated cognitive decline

Negative wealth shock linked to accelerated cognitive decline

by Elana GotkineFor older adults, negative wealth shock is associated with accelerated cognitive decline and increased risks for dementia, according to a study published online Dec. 26 inJAMA Ne
Neurology February 24,2024
Negative wealth shock linked to accelerated cognitive decline

Negative wealth shock linked to accelerated cognitive decline

by Elana GotkineFor older adults, negative wealth shock is associated with accelerated cognitive decline and increased risks for dementia, according to a study published online Dec. 26 inJAMA Ne
Neurology February 24,2024
What is the difference between Alzheimer's and dementia?

What is the difference between Alzheimer's and dementia?

by Erin Kayata,Northeastern UniversityNikolai Slavov works in his lab at the Mugar Life Sciences Building. Credit: Ruby Wallau/Northeastern UniversityAlzheimer's and related forms of dementi
Neurology February 24,2024
What is the difference between Alzheimer's and dementia?

What is the difference between Alzheimer's and dementia?

by Erin Kayata,Northeastern UniversityNikolai Slavov works in his lab at the Mugar Life Sciences Building. Credit: Ruby Wallau/Northeastern UniversityAlzheimer's and related forms of dementi
Neurology February 24,2024
Cell-type-specific genetic risk contributes to distinct stages of Alzheimer's disease progression, finds study

Cell-type-specific genetic risk contributes to distinct stages of Alzheimer's disease progression, finds study

by Brigham and Women's HospitalCell-type-specific Alzheimer’s disease polygenic risk scores (ADPRS).aA schematic of cell-type-specific PRS derivation.bAn UpSetR plot o
Neurology February 24,2024
Cell-type-specific genetic risk contributes to distinct stages of Alzheimer's disease progression, finds study

Cell-type-specific genetic risk contributes to distinct stages of Alzheimer's disease progression, finds study

by Brigham and Women's HospitalCell-type-specific Alzheimer’s disease polygenic risk scores (ADPRS).aA schematic of cell-type-specific PRS derivation.bAn UpSetR plot o
Neurology February 24,2024
High levels of HDL cholesterol tied to higher dementia risk

High levels of HDL cholesterol tied to higher dementia risk

by Lori SolomonElevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 inThe L
Neurology February 24,2024
High levels of HDL cholesterol tied to higher dementia risk

High levels of HDL cholesterol tied to higher dementia risk

by Lori SolomonElevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 inThe L
Neurology February 24,2024
Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment

Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment

by Bridjes O'Neil,Saint Louis UniversityGraphical Abstract. Credit:JAMA Neurology(2023). DOI: 10.1001/jamaneurol.2023.3810A Saint Louis University researcher was instrumental in
Neurology February 24,2024
Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment

Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment

by Bridjes O'Neil,Saint Louis UniversityGraphical Abstract. Credit:JAMA Neurology(2023). DOI: 10.1001/jamaneurol.2023.3810A Saint Louis University researcher was instrumental in
Neurology February 24,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com